129 related articles for article (PubMed ID: 37023940)
1. HDAC4 mediated LHPP deacetylation enhances its destabilization and promotes the proliferation and metastasis of nasopharyngeal carcinoma.
Sun X; Zhang K; Peng X; Zhou P; Qu C; Yang L; Shen L
Cancer Lett; 2023 May; 562():216158. PubMed ID: 37023940
[TBL] [Abstract][Full Text] [Related]
2. HDAC4 promotes nasopharyngeal carcinoma progression and serves as a therapeutic target.
Cheng C; Yang J; Li SW; Huang G; Li C; Min WP; Sang Y
Cell Death Dis; 2021 Feb; 12(2):137. PubMed ID: 33542203
[TBL] [Abstract][Full Text] [Related]
3. LHPP suppresses tumorigenesis of intrahepatic cholangiocarcinoma by inhibiting the TGFβ/smad signaling pathway.
Wang D; Ning Z; Zhu Z; Zhang C; Wang P; Meng Z
Int J Biochem Cell Biol; 2021 Mar; 132():105845. PubMed ID: 33401010
[TBL] [Abstract][Full Text] [Related]
4. MTA1 promotes viability and motility in nasopharyngeal carcinoma by modulating IQGAP1 expression.
Lu B; Lian R; Wu Z; Miao W; Li X; Li J; Shi Y; Yu W
J Cell Biochem; 2018 May; 119(5):3864-3872. PubMed ID: 29125886
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor LHPP suppresses cell proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma cell lines.
Ma L; Sun H; Xu X; Chen Y; Zhang L; Li S; Tang L
J Physiol Biochem; 2022 Nov; 78(4):807-817. PubMed ID: 35796893
[TBL] [Abstract][Full Text] [Related]
6. HDAC7 promotes the oncogenicity of nasopharyngeal carcinoma cells by miR-4465-EphA2 signaling axis.
Li QG; Xiao T; Zhu W; Yu ZZ; Huang XP; Yi H; Lu SS; Tang YY; Huang W; Xiao ZQ
Cell Death Dis; 2020 May; 11(5):322. PubMed ID: 32376822
[TBL] [Abstract][Full Text] [Related]
7.
Liao L; Duan D; Liu Y; Chen L
Cell Cycle; 2020 Jul; 19(14):1846-1854. PubMed ID: 32578511
[TBL] [Abstract][Full Text] [Related]
8. Correlated with better prognosis, CSTA inhibits metastasis of nasopharyngeal carcinoma cells via suppressing AKT signaling through promoting METTL3 degradation.
Liu ZJ; Zheng LS; Li CZ; Peng LX; Mei Y; Lang YH; Xu L; Meng DF; Peng XS; Wang MD; Xie DH; Guo LL; Ding LY; Huang BJ; Qian CN
Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166696. PubMed ID: 36963524
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway.
Wu Q; Xiang M; Wang K; Chen Z; Long L; Tao Y; Liang Y; Yan Y; Xiao Z; Qiu S; Yi B
Curr Cancer Drug Targets; 2020; 20(8):624-637. PubMed ID: 32329689
[TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway.
Hou B; Li W; Li J; Ma J; Xia P; Liu Z; Zeng Q; Zhang X; Chang D
Oncol Rep; 2020 Feb; 43(2):536-548. PubMed ID: 31894339
[TBL] [Abstract][Full Text] [Related]
11. Three LHPP gene-targeting co-expressed microRNAs (microRNA-765, microRNA-21, and microRNA-144) promote proliferation, epithelial-mesenchymal transition, invasion, and are independent prognostic biomarkers in renal cell carcinomas patients.
Meng K; Li Z; Cui X
J Clin Lab Anal; 2021 Dec; 35(12):e24077. PubMed ID: 34699621
[TBL] [Abstract][Full Text] [Related]
12. LHPP suppresses proliferation, migration, and invasion in hepatocellular carcinoma and pancreatic cancer by inhibiting EGFR signaling pathway.
Zhu H; Song C; Li J; Liu Q; Liu M; Fu L
Med Oncol; 2023 Jul; 40(9):257. PubMed ID: 37522936
[TBL] [Abstract][Full Text] [Related]
13. LHPP suppresses proliferation, migration, and invasion and promotes apoptosis in pancreatic cancer.
Wu F; Chen Y; Zhu J
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32186702
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of LHPP by saRNA inhibited hepatocellular cancer cell proliferation and xenograft tumor growth.
Bi CQ; Kang T; Qian YK; Kang M; Zeng XH; Li LC
PLoS One; 2024; 19(5):e0299522. PubMed ID: 38696452
[TBL] [Abstract][Full Text] [Related]
15. CircHIPK3 promotes proliferation and invasion in nasopharyngeal carcinoma by abrogating miR-4288-induced ELF3 inhibition.
Ke Z; Xie F; Zheng C; Chen D
J Cell Physiol; 2019 Feb; 234(2):1699-1706. PubMed ID: 30070690
[TBL] [Abstract][Full Text] [Related]
16. LASP1 promotes nasopharyngeal carcinoma progression through negatively regulation of the tumor suppressor PTEN.
Gao Q; Tang L; Wu L; Li K; Wang H; Li W; Wu J; Li M; Wang S; Zhao L
Cell Death Dis; 2018 Mar; 9(3):393. PubMed ID: 29531214
[TBL] [Abstract][Full Text] [Related]
17. LHPP inhibits cell growth and migration and triggers autophagy in papillary thyroid cancer by regulating the AKT/AMPK/mTOR signaling pathway.
Sun W; Qian K; Guo K; Chen L; Xiang J; Li D; Wu Y; Ji Q; Sun T; Wang Z
Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):382-389. PubMed ID: 32227107
[TBL] [Abstract][Full Text] [Related]
18. DNTTIP1 promotes nasopharyngeal carcinoma metastasis via recruiting HDAC1 to DUSP2 promoter and activating ERK signaling pathway.
Ding S; Gao Y; Lv D; Tao Y; Liu S; Chen C; Huang Z; Zheng S; Hu Y; Chow LK; Wei Y; Feng P; Dai W; Wang X; Xia Y
EBioMedicine; 2022 Jul; 81():104100. PubMed ID: 35689852
[TBL] [Abstract][Full Text] [Related]
19. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
Hu W; Xiao L; Cao C; Hua S; Wu D
Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
[TBL] [Abstract][Full Text] [Related]
20. LHPP promotes the intracellular reactive oxygen species accumulation and sensitivity of gastric cancer to cisplatin via JNK and p38 MAPK pathways.
Gao K; Yin N; Shen Z; Li Q; Chen P; Yang K
Histol Histopathol; 2023 Sep; 38(9):1055-1068. PubMed ID: 36546683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
